Clinical Trial Update: A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating latanoprost delivered via a punctal plug system (L-PPDS) for open-angle glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost punctal plug delivery system (L-PPDS) (latanoprost)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED